montelukast sodium + levocetirizine hydrochloride Tablets 10 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20245
This pharmaceutical company specializes in ophthalmic and ENT products, offering a wide range of eye drops, ear drops, nasal sprays, and oral medications. Their product portfolio includes anti-inflammatory, antibiotic, anti-allergic, lubricant, and glaucoma treatment options. They also produce antioxidants and gastrointestinal medications. Key therapy areas include dry eye, infectious eye disease, allergic eye disease, inflammatory eye disease, and ear infections. Principal dosage forms encompass eye drops, ointments, ear drops, nasal sprays, and tablets. The company operates in regions such as the EU and North America, with a focus on providing affordable and accessible healthcare solutions.
None